Team Member
Team Member

Bloomberg Lvl. 1
initiate


90xp 100% Complete (success)

Crypto Doesn’t Belong in Politics: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that candidates should do their best to ignore digital currency advocates, despite their huge campaign finance war chests.

Ban on Doctor-Owned Hospitals Has Backfired: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that Congress should reverse a policy that stymies much-needed competition.

The US Needs to Start Talking About Taxes: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that the expiration of the Tax Cuts and Jobs Act of 2017 is a chance to start repairing the country’s public finances.

Europe and China Can Avoid an EV Trade War: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that a peaceful agreement establishing fairer competition would be good for consumers, business and the environment.

Is Private Equity a Threat? It’s Hard to Say: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that the proliferation of leverage in an opaque realm should raise concerns.

The H-1B Lottery Is Too Easily Gamed: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that visas for highly skilled workers should be awarded by talent, not luck.

Housing Should Be a Priority for Candidates: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that politicians from both parties must offer better solutions to make housing more affordable.

UK Riots Are Keir Starmer’s First Big Test: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that the government needs a strong criminal justice system and a functional immigration policy to prevent a repeat.

Everyone Wants the Government to Do Better: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that no matter their politics, Americans agree that a more effective federal bureaucracy is needed. Now’s the time to focus on it.

Permit Reform Is a Win for Clean Energy: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that a new deal in Congress to streamline clean-energy projects is a victory for common sense.

How to Fix Britain’s Skills Deficit: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that the UK must fix its dysfunctional system of apprenticeships and vocational training. The government has left too many young people with few opportunities.

Doctors Need Clarity on Emergency Abortions: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that lawmakers must pass more detailed legislation to protect women's access to necessary care. 

The Fates of Ukraine and NATO Are Linked: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that Europe must accelerate efforts to improve its own defenses and industrial cooperation. 

The US Must Convince More Citizens to Serve: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that militaries don’t just need more weapons to deter Russia and China — they need soldiers to man them. 

Europe Needs the Right Kind of Finance: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that securitization has a bad reputation, but it can do a lot of good.  

Joe Biden Chooses His Country and Conscience: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that the president made an honorable choice by giving up the trappings of power for the good of the country.  

Want Cheaper Prescriptions? Start Bargaining: Opinion (Podcast)

post
Bloomberg Opinion editor Rachel Rosenthal presents an editorial arguing that with the right reforms, expanding drug-price negotiations can lower costs without impeding innovation.